Molbio Diagnostics surges 7%: Why Jefferies forecasts 47% profit surge in 3 years
- Posted on September 30, 2026
- By Financial Express
- 2 Views
- 1 min read
In brief
Generating AI summary…
Molbio Diagnostics surges 7%: Why Jefferies forecasts 47% profit surge in 3 years
Molbio Diagnostics is entering a faster-growth phase, with Jefferies seeing Truenat expansion and the scaling of Prognosys and OptraScan as key earnings drivers.
